To determine whether the redox state of HMGB1-ΔC might affect its hypothetical cytotoxic activity towards cancer cells, HeLa cervix carcinoma cells were treated with HMGB1-∆C in the presence or absence of DTT and the cell viability assessed (Figure 1E). This evidence concerns the gene HMGB1 and cervical carcinoma.